Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
The Breast Journal|January 1, 2025
Brain Metastasis in Triple-Negative Breast CancerEduarda Bustamante, Fresia Casas, Renato Luque, et al.
Frontiers in Cardiovascular Medicine|March 25, 2024
Reduced mitochondrial pyruvate carrier expression in hearts with heart failure and reduced ejection fraction patients: ischemic vs. non-ischemic originPaula Lopez-Vazquez, Mariana Fernandez-Caggiano, Eduardo Barge-Caballero, et al.
Plos One|October 27, 2025
Survival outcomes and prognostic factors in children and adults with medulloblastoma from a Latin America country: A retrospective cohortMichael Mallouh, Gabriel De la Cruz-Ku, Renato Luque-Benavides, et al.
The Breast Journal|July 27, 2020
Lymph node ratio as best prognostic factor in triple-negative breast cancer patients with residual disease after neoadjuvant chemotherapyGabriel A De la Cruz-Ku, Diego Chambergo-Michilot, Bryan Valcarcel, et al.
Oncotarget|December 17, 2017
Comparative analysis of primary versus relapse/refractory DLBCL identifies shifts in mutation spectrumDanielle M Greenawalt, Winnie S Liang, Sakina Saif, et al.
BMC Medical Genomics|October 21, 2017
A method to reduce ancestry related germline false positives in tumor only somatic variant callingRebecca F Halperin, John D Carpten, Zarko Manojlovic, et al.
Breast Disease|January 7, 2020
Breast-conserving surgery vs. total mastectomy in patients with triple negative breast cancer in early stages: A propensity score analysisGabriel De-la-Cruz-Ku, Bryan Valcarcel, Zaida Morante, et al.
Hernia : the Journal of Hernias and Abdominal Wall Surgery|May 12, 2026
Comparison of short-term outcomes between open and minimally invasive surgery for emergent parastomal hernia repair: A retrospective propensity score-matched analysisGabriel De la Cruz Ku, Alejandro Garcia, Cassandra Burke, et al.
Scientific Reports|April 21, 2016
A somatic reference standard for cancer genome sequencingDavid W Craig, Sara Nasser, Richard Corbett, et al.
Hematology (Amsterdam, Netherlands)|February 22, 2022
Venetoclax-based combinations for acute myeloid leukemia: optimizing their use in Latin-AmericaAndrés Gómez-De León, Roberta Demichelis-Gómez, Alfredo Pinedo-Rodríguez, et al.
Pageof 5